Meinian Onehealth Healthcare Holdings (SZSE:002044) Stock Falls 4.4% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend
Meinian Onehealth Healthcare Holdings (SZSE:002044) Stock Falls 4.4% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend
Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly. For example, after five long years the Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) share price is a whole 62% lower. We certainly feel for shareholders who bought near the top. And some of the more recent buyers are probably worried, too, with the stock falling 41% in the last year. The falls have accelerated recently, with the share price down 23% in the last three months.
總體而言,長期投資是值得的,但是在路上有些股票會表現不佳。例如,五年後,美年健康(股票代碼:SZSE:002044)的股價已經下跌了整整62%。我們確實爲那些接近買入高點的股東感到難過。而一些更近期的買家也可能感到擔憂,股價在過去一年中下跌了41%。最近跌勢加速,股價在過去三個月下跌了23%。
Since Meinian Onehealth Healthcare Holdings has shed CN¥700m from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics.
由於在過去7天中,美年健康(股票代碼:SZSE:002044)市值已減少了7億元,讓我們看看長期的下跌是否受到業務經濟的推動。
While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).
雖然有效市場假說仍然被一些人教授,但被證明市場是過度反應的動態系統,投資者並不總是理性的。檢查市場情緒如何隨時間變化的一種方法是看一個公司的股價與其每股收益(EPS)之間的交互作用。
Meinian Onehealth Healthcare Holdings became profitable within the last five years. That would generally be considered a positive, so we are surprised to see the share price is down. Other metrics might give us a better handle on how its value is changing over time.
美年健康在過去五年內實現了盈利。這通常被認爲是好事,所以我們對股價下跌感到驚訝。其他指標可能能更好地幫我們了解其價值如何隨時間變化。
We don't think that the 0.5% is big factor in the share price, since it's quite small, as dividends go. In contrast to the share price, revenue has actually increased by 5.5% a year in the five year period. So it seems one might have to take closer look at the fundamentals to understand why the share price languishes. After all, there may be an opportunity.
我們認爲0.5%對於股價來說不是很重要,因爲它相當小,與股息相比。相比股價,營業收入實際上在過去五年中年增長5.5%。所以看起來必須更仔細地了解基本面才能理解爲什麼股價疲軟。畢竟,可能存在機會。
You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).
你可以在下面的圖片中看到收入和營業收入隨時間的變化情況(單擊圖表可查看精確值)。
We know that Meinian Onehealth Healthcare Holdings has improved its bottom line lately, but what does the future have in store? If you are thinking of buying or selling Meinian Onehealth Healthcare Holdings stock, you should check out this free report showing analyst profit forecasts.
我們知道美年健康(股票代碼:SZSE:002044)最近改善了其底線,但未來會怎樣?如果您正考慮購買或出售美年健康(股票代碼:SZSE:002044),則應查看此免費報告,顯示分析師盈利預測。
A Different Perspective
不同的觀點
While the broader market lost about 14% in the twelve months, Meinian Onehealth Healthcare Holdings shareholders did even worse, losing 41% (even including dividends). However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 10% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. Before forming an opinion on Meinian Onehealth Healthcare Holdings you might want to consider these 3 valuation metrics.
雖然整個市場在十二個月中損失了約14%,但美年健康(股票代碼:SZSE:002044)的股東表現更糟糕,股價下跌了41%(包括股息)。但是,這可能僅是因爲股價受到更廣泛的市場焦慮的影響。可能值得密切關注基本面,以防出現良好的機會。遺憾的是,去年的表現結束了一段糟糕的時期,股東面臨着每年總計10%的虧損。我們意識到Baron Rothschild曾說過投資者應該“在街上流血時購買”,但我們警告投資者首先要確保他們購買的是高質量的公司。在對美年健康(股票代碼:SZSE:002044)形成意見之前,您可能要考慮這三個估值指標。
Of course Meinian Onehealth Healthcare Holdings may not be the best stock to buy. So you may wish to see this free collection of growth stocks.
當然,美年健康(股票代碼:SZSE:002044)可能不是最好的股票購買對象。因此,您可能希望查看這些增長股的免費收藏。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,也可以發送電子郵件至editorial-team@simplywallst.com